CRVO: CervoMed Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 7.38
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 7.37
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.29
Return on Assets (ROA) -0.66
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.84
Current Ratio 3.84

Balance Sheet (mrq) ($M)
Current Assets 9.96
Assets 9.97
Liabilities 2.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.14
Operating Income -7.01
Net Income -2.17
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.45
Cash from Investing 0.00
Cash from Financing 11.15

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-11 13G Ra Capital Management, L.p. 9.99
03-06 13G/A AI EIPP Holdings LLC 0.74 -90.06
02-28 13D/A Boger Joshua S 17.10 88.36
08-28 13D Zavrl Frank 6.40 0.00
08-28 13D Alam John J 26.20 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 2,803 30,139 9.30
2024-04-25 3,920 25,467 15.39
2024-04-24 4,702 5,739 81.93
2024-04-23 3,614 4,115 87.83
2024-04-22 2,832 8,445 33.53

(click for more detail)

Similar Companies
CRBP – Corbus Pharmaceuticals Holdings, Inc. CRDF – Cardiff Oncology, Inc.
CRIS – Curis, Inc. CSBR – Champions Oncology, Inc.
CTXR – Citius Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io